Directly or indirectly, cancer will touch everyone's lives. There is no greater or more worthwhile challenge than the ongoing battle to develop and improve anti-cancer treatments, for everyone's sake.
 |
programme of research
University of York
2004/5
YCR Cancer Research Unit
Director: Professor N J Maitland
L. Stanbridge
N.J. Maitland
Targeting of baculoviral vectors to the prostate for gene therapy.
J.E. Burns
N.J. Maitland
Structure and functional studies of human papillomavirus E2 proteins.
J.E. Burns
N.J. Maitland
Interaction of HPV E1 protein with human topoisomerase I.
A. Collins
N.J. Maitland
Identification of cancer stem cells in human prostate tumours.
A. Collins
N.J. Maitland
The role of androgen signalling in the regulation of human prostate epithelial stem cell differentiation.
S.D. Bryce
A. Collins
N.J. Maitland
Genotyping prostate cancer stem cells using SNP genechip arrays.
R.M. Sharrard
N.J. Maitland
Alterations in the activation pathway of protein kinase B in the progression to metastasis of human prostate cancer.
YORKSHIRE CANCER RESEARCH P53 RESEARCH GROUP
Director of Unit: Professor A. J. Milner
R.E. Adamson
S.J.Allison
J. Milner
The effect of phosphorylated p53 on site-specific histone H3 modifications.
S.J. Allison
J. Milner
Remodelling chromatin on a global scale: a novel protective function of p53.
J.R. Ford
J. Milner
P53 acetylation.
M. Jiang
J. Milner
RNAi and apoptotic pathways.
C. Lynch
J. Milner
Effects of p53 gene dosage upon the DNA damage response.
C.P. Rubbi
J. Milner
P53 and DNA repair.
L.J. Warnock
S.A. Raines
J. Milner
P53 protein: structures and modifications.
Department of Biology
Head of Department: Professor A.H. Fitter
Dr D Coverley
Regulation of initiation of mammalian DNA replication by Ciz1.
Department of Chemistry
Head of Department: Professor P.H Walton
Prof. R. J. K. Taylor
Novel anti-tumour agents from marine natural products.
|